1. Home/
  2. Compounds/
  3. sirolimus:bortezomib (250:1 mol/mol)

sirolimus:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2sirolimus:bortezomib (250:1 mol/mol)
PharmacoGx sirolimus:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to sirolimus:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA AANAT CTRPv2 pan-cancer AAC 0.092 0.005
mRNA ABC13-47488600E17.1 CTRPv2 pan-cancer AAC -0.089 0.009
mRNA ABCA5 CTRPv2 pan-cancer AAC 0.09 0.007
mRNA ABCA7 CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA ABCC4 CTRPv2 pan-cancer AAC -0.089 0.01
mRNA ABCD2 CTRPv2 pan-cancer AAC 0.12 0.0006
mRNA ABHD3 CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA ABI1 CTRPv2 pan-cancer AAC 0.097 0.006
mRNA AC005281.1 CTRPv2 pan-cancer AAC 0.094 0.008
mRNA AC005338.1 CTRPv2 pan-cancer AAC 0.1 0.007
Download CSV